These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24239300)

  • 1. Acute epigastric and low back pain during amiodarone infusion; is it the drug or the vehicle to blame?
    Petrou E; Iakovou I; Boutsikou M; Girasis C; Mavrogeni S; Pavlides G
    Heart Lung; 2014; 43(1):60-1. PubMed ID: 24239300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute disabling low-back pain during intravenous administration of amiodarone: could intravenous to oral switch therapy be a safe strategy?
    Manzano-Fernández S; Sánchez M; Moreno-Flores V; García-Alberola A
    Cardiology; 2010; 117(4):275-7. PubMed ID: 21273769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute low back pain during intravenous administration of amiodarone: a report of two cases.
    Korantzopoulos P; Pappa E; Karanikis P; Kountouris E; Dimitroula V; Siogas K
    Int J Cardiol; 2005 Feb; 98(2):355-7. PubMed ID: 15686794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute severe back pain radiating to the whole body during intravenous administration of amiodarone.
    Yan Y; Shen H
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):561-2. PubMed ID: 25907175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low back pain following intravenous administration of amiodarone.
    Tsikrikas S; Charalampous C; Letsas KP; Efremidis M; Sideris A
    Hellenic J Cardiol; 2010; 51(6):544-5. PubMed ID: 21169188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hepatitis complicating parenteral amiodarone does not preclude subsequent oral therapy.
    James PR; Hardman SM
    Heart; 1997 Jun; 77(6):583-4. PubMed ID: 9227310
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute hepatitis caused by intravenous amiodarone].
    Paniagua Clusells J; Arcusa Gavalda R; Goma Masip F; Pons Masanes S; Soler Masana JM
    Rev Esp Cardiol; 1996 May; 49(5):384-5. PubMed ID: 8744394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early-onset acute toxic hepatitis induced by intravenous amiodarone administration].
    González Galilea A; García Sánchez MV; la Mata García M; Miño Fugarolas G
    Gastroenterol Hepatol; 2002; 25(6):392-4. PubMed ID: 12069701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low back pain induced by i.v. amiodarone.
    Adams ML; Kujawski SZ; Bollinger J; Prom R
    Am J Health Syst Pharm; 2014 May; 71(10):782-4. PubMed ID: 24780481
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatotoxicity after intravenous amiodarone.
    Cataldi A; Gonella D; Robutti N; Siri M; Buonocore S; Odetti P
    Aging Clin Exp Res; 2008 Dec; 20(6):593-6. PubMed ID: 19179845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicity.
    Giannattasio F; Salvio A; Varriale M; Picciotto FP; Di Costanzo GG; Visconti M
    Ann Ital Med Int; 2002; 17(3):180-4. PubMed ID: 12402666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute liver injury after intravenous amiodarone: a case report.
    Verhovez A; Elia F; Riva A; Ferrari G; Aprà F
    Am J Emerg Med; 2011 Sep; 29(7):843.e5-6. PubMed ID: 20870371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hepatitis complicating intravenous amiodarone treatment.
    Agozzino F; Picca M; Pelosi G
    Ital Heart J; 2002 Nov; 3(11):686-8. PubMed ID: 12506529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxicity during rapid intravenous loading with amiodarone: Description of three cases and review of the literature.
    Rätz Bravo AE; Drewe J; Schlienger RG; Krähenbühl S; Pargger H; Ummenhofer W
    Crit Care Med; 2005 Jan; 33(1):128-34; discussion 245-6. PubMed ID: 15644659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal acute liver failure after intravenous amiodarone administration.
    Li JG; Yang TC; Yu DM; Ren TH
    J Formos Med Assoc; 2015 Mar; 114(3):294-6. PubMed ID: 23953514
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic cardioversion with intravenous amiodarone is likely safe in neurocritically Ill patients.
    Su M; Seki D; Moheet AM
    J Clin Neurosci; 2017 May; 39():59-61. PubMed ID: 28209460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute hepatotoxicity from intravenous amiodarone in a patient on hemodialysis].
    Bucco S; Arazzi M; Giunta F; Grabocka X; Longo MO; Silvestri S; Spetrino N; Tondo M; Vigilante G; Bonomini M
    G Ital Nefrol; 2016; 33(1):. PubMed ID: 26913742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs.
    Bonora A; Turcato G; Franchi E; Taioli G; Dilda A; Zerman G; Maccagnani A; Pistorelli C; Olivieri O
    Intern Emerg Med; 2017 Sep; 12(6):853-859. PubMed ID: 27384766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle?
    Rhodes A; Eastwood JB; Smith SA
    Gut; 1993 Apr; 34(4):565-6. PubMed ID: 8491409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stunning of the left atrium after pharmacological cardioversion of atrial fibrillation.
    Zapolski T; Wysokiński A
    Kardiol Pol; 2005 Sep; 63(3):254-62; discussion 263-4. PubMed ID: 16180181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.